Evidence map›Paper›PMID 28642324›Full record

ReviewCirculation research2017

Direct Stimulation of Cardiogenesis: A New Paradigm for Treating Heart Disease.

James F Martin, Emerson C Perin, James T Willerson

Abstract readReview
In one paragraph

Review in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Hippo Pathway Knockdown Gene Therapy in the Heart.Texas Heart Institute journal · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James F MartinFrom the Cardiomyocyte Renewal Laboratory (J.F.M.) and the Division of Cardiology Research (E.C.P., J.T.W.), Texas Heart Institute, Houston; and the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.). jwillerson@texasheart.org jmartin@texasheart.org.
Emerson C PerinFrom the Cardiomyocyte Renewal Laboratory (J.F.M.) and the Division of Cardiology Research (E.C.P., J.T.W.), Texas Heart Institute, Houston; and the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.).
James T WillersonFrom the Cardiomyocyte Renewal Laboratory (J.F.M.) and the Division of Cardiology Research (E.C.P., J.T.W.), Texas Heart Institute, Houston; and the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.). jwillerson@texasheart.org jmartin@texasheart.org.

Funding

Pitx2 in atrial fibrillationR01HL118761 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2014 to 2025
$6.1M
Hippo and Wnt Signaling in Cardiac RegenerationR01HL127717 · NHLBI · TEXAS HEART INSTITUTE · PI MARTIN, JAMES F · 2016 to 2023
$4.4M
Optical elastography for assessment of myocardial regenerationR01HL130804 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LARIN, KIRILL V, MARTIN, JAMES F · 2016 to 2019
$2.9M
MicroRNAs in cleft lip and palateR01DE023177 · NIDCR · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2013 to 2017
$2.8M
NHLBI NIH HHS R01 HL118761NHLBI NIH HHS R01 HL127717NHLBI NIH HHS R01 HL130804NIDCR NIH HHS R01 DE023177
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHeartHeart DiseasesHeart FailureHippo Signaling PathwayHumansOrganogenesisProtein Serine-Threonine KinasesTreatment OutcomeProtein Serine-Threonine Kinasescardiogenesisheart failuremyocardial infarctiontreatment

Identifiers

PMID28642324
PMCPMC5545096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.